Patent · US Active

H-FABP as early predictor of myocardial infarction

US8062857B1 · kind B1 · utility

0Cited by

1References

13Claims

0Family size

Assignee

Roche Diagnostics Operations, Inc. · US

Inventors

Georg Hess · Mainz, DE
Hendrik Huedig · Penzberg, DE
Rosemarie Kientsch-Engel · Feldafing, DE
Dietmar Zdunek · Tutzing, DE

Key dates

Filing date	Nov 23, 2009
Grant date	Nov 22, 2011
Priority date	—
Expiry date	Mar 13, 2030

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/324
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The present invention relates to a method for diagnosing myocardial infarction in a subject who suffers from acute coronary syndrome and has a cardiac troponin level which is detectable but lower than the level that is considered as being indicative for a myocardial infarction. Moreover, the present invention relates to a method for identifying a subject being susceptible to cardiac intervention, wherein the subject suffers from acute coronary syndrome and has a cardiac troponin level which is detectable but lower than a level that is considered as being indicative for a myocardial infarction. The methods of the present invention are based on the determination of H-FABP and, optionally, myoglobin in a sample of the subject and comparing the amount of H-FABP and, optionally, myoglobin to reference amounts.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.